View Clause Headings                                                                                                                                               HelpHelp
DOCUMENT TITLE:  PROMOTION AGREEMENT .
ACTIONS: Here are the clause headings in the document. To view the clause, click the clause heading.To view the full document, click the "View Document" button.

View Document Back
Clause Heading
Section 2.1 - Grant of Promotion Rights
Section 2.2 - Sublicense
Section 2.3 - Limitation on Metformin Promotion
Section 2.4 - Retention of Rights
Section 3.1 - Establishment
Section 3.2 - Joint Commercialization Committee
Section 3.3 - JCC Responsibilities
Section 3.4 - Meetings of the JCC.
Section 3.5 - JCC Disputes
Section 4.1 - Product Promotion
Section 4.2 - Representations to Customers
Section 4.3 - Staffing; Training
Section 4.4 - Promotional Materials; Educational Materials
Section 4.5 - Annual Plan; Promotion Expenses
Section 4.6 - Santarus Promotion Reports
Section 4.7 - Medical Inquiries
Section 4.8 - Trademarks
Section 4.9 - Election by Depomed to Promote in the Territory
Section 4.10 - Product Website
Section 5.1 - Regulatory Approvals
Section 5.2 - Compliance with Regulatory Requirements
Section 5.3 - Compliance
Section 5.4 - Communications with Regulatory Authorities
Section 5.5 - Product Complaints
(a) - Each party shall notify the other:
Section 5.7 - Recalls or Other Corrective Action
Section 5.8 - Assistance
Section 6.1 - Obligations of Depomed
Section 6.2 - Manufacturing Activities
Section 6.3 - Volume Forecasts; Wholesaler Activities
Section 6.4 - Sales; Pricing
Section 6.5 - Samples
Section 6.6 - Manufacturing Matters; Inability to Supply.
Section 6.7 - Third Party Agreements
Section 7.1 - Santarus Payments
Section 7.2 - Promotion Fees
(v) - COGS during such Agreement Month;
(vii) - Gross Margin for such Agreement Month.
Section 7.3 - Maintenance of Records
Section 7.4 - Payments
Section 7.5 - Tail Promotion Fees
Section 7.6 - Depomed Percentage
Section 8.1 - Term
Section 8.2 - Early Termination
Section 8.3 - Termination for Cause
Section 8.4 - Termination for Bankruptcy or Force Majeure
Section 8.5 - Force Majeure
Section 8.6 - Effect of Termination
Section 9.1 - Representations and Warranties of Depomed
(a) - Organization.
(b) - Authorization.
(c) - No Conflict.
(d) - Enforceability.
(e) - Broker.
(f) - Depomed Intellectual Property.
(g) - Litigation.
(h) - Documentation.
(i) - Supply.
(j) - Generic Drug Act.
(k) - Legal Requirements.
(l) - NDA Acquisition.
(m) - BLS Agreements.
(n) - Patheon Agreement.
(o) - Inventory Levels.
Section 9.2 - Representations and Warranties of Santarus
(f) - Santarus Trademarks.
(h) - Generic Drug Act.
(i) - Legal Requirements.
Section 9.3 - Depomed Disclaimer
Section 9.4 - Santarus Disclaimer
Section 10.1 - Intellectual Property Prosecution and Maintenance
Section 10.2 - Third Party Competition
Section 10.3 - Infringement
Section 11.1 - Indemnification
Section 11.2 - Consequential Damages
Section 12.1 - Proprietary Information
Section 12.2 - Disclosures Required by Law
Section 14.1 - Notices
Section 12.3 - Publicity
ARTICLE XIII - RIGHT OF FIRST NEGOTIATION FOR CERTAIN COMBINATION PRODUCTS;
Section 13.1 - Right of First Negotiation
Section 13.2 - Exclusivity
Section 15.1 - Insurance
Section 16.1 - Headings
Section 16.2 - Severability
Section 16.3 - Entire Agreement
Section 16.4 - Amendments
Section 16.5 - Counterparts
Section 16.6 - Waiver
Section 16.7 - Force Majeure
Section 16.8 - Successors and Assigns
Section 16.9 - Assignment
Section 16.10 - Construction
Section 16.11 - Governing Law
Section 16.12 - Equitable Relief
Section 16.13 - Relationship Between Parties